Clinical Trial Update: Effect of BMS-914392 on Pharmacokinetics of Metoprolol [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of BMS-914392 on the pharmacokinetics of metoprolol in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• BMS-914392 (BMS-914392)
• METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation | Phase 1 | Status: COMPLETED